ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages 20206-20211

  Jansen, Robert S ^a   Küçükosmanoǧlu, Asli ^a   De Haas, Marcel ^a   Sapthu, Sunny ^a   Otero, Jon Andoni ^b   Hegman, Ilse E M ^a   Bergen, Arthur A B ^c,d   Gorgels, Theo G M F ^c   Borst, P ^a   Van De Wetering, Koen ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF LEÓN   (Spain)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ATP secretion; Ectopic calcification; ENPP1; MRP6

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASSETTE SUB FAMILY C MEMBER 6 PROTEIN; NUCLEOSIDE TRIPHOSPHATE; PYROPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; METABOLOMICS; MINERALIZATION; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOXANTHOMA ELASTICUM;

EID: 84890275902     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319582110     Document Type: Article

References (55)

1. Neldner KH (1988) Pseudoxanthoma elasticum. Clin Dermatol 6(1):1-159.
2. Uitto J, Váradi A, Bercovitch L, Terry PF, Terry SF (2013) Pseudoxanthoma elasticum: Progress in research toward treatment. Summary of the 2012 PXE international research meeting. J Invest Dermatol 133(6):1444-1449.
3. Uitto J, Li Q, Jiang Q (2010) Pseudoxanthoma elasticum: Molecular genetics and putative pathomechanisms. J Invest Dermatol 130(3):661-670.
4. Le Saux O, et al. (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25(2):223-227.
5. Bergen AA, et al. (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25(2):228-231.
6. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J (2000) Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 97(11):6001-6006.
7. Struk B, et al. (2000) Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J Mol Med (Berl) 78(5):282-286.
8. Borst P, Evers R, Kool M, Wijnholds J (2000) A family of drug transporters: Tthe multidrug resistance-associated proteins. J Natl Cancer Inst 92(16):1295-1302.
9. Kool M, van der Linden M, de Haas M, Baas F, Borst P (1999) Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59(1):175-182.
10. Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B (2000) Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 57(3):634-641.
11. Scheffer GL, et al. (2002) MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82(4):515-518.
12. Le Saux O, et al. (2011) Expression and in vivo rescue of human ABCC6 disease-causing mutants in mouse liver. PLoS ONE 6(9):e24738.
13. Gorgels TG, et al. (2012) Abcc6 deficiency in the mouse leads to calcification of collagen fibers in Bruch's membrane. Exp Eye Res 104:59-64.
14. Jiang Q, Li Q, Uitto J (2007) Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: Systemic and local regulatory factors. J Invest Dermatol 127(6):1392-1402.
15. Klement JF, et al. (2005) Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 25(18):8299-8310.
16. Gorgels TG, et al. (2005) Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14(13):1763-1773.
17. Jiang Q, Endo M, Dibra F, Wang K, Uitto J (2009) Pseudoxanthoma elasticum is a metabolic disease. J Invest Dermatol 129(2):348-354.
18. -/- mice and their wild-type counterparts halts ectopic mineralization in a murine model of pseudoxanthoma elasticum. Am J Pathol 176(4):1855- 1862.
19. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD (2002) Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62(21):6172-6177.
20. Iliás A, et al. (2002) Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277(19):16860-16867.
21. Borst P, van de Wetering K, Schlingemann R (2008) Does the absence of ABCC6 (multidrug resistance protein 6) in patients with pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery? Cell Cycle 7(11):1575-1579.
22. Markello TC, et al. (2011) Vascular pathology of medial arterial calcifications in NT5E deficiency: Implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab 103(1):44-50.
23. Fülöp K, et al. (2011) ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: Relevance to pathomechanisms of pseudoxanthoma elasticum. Biochem Biophys Res Commun 415(3):468-471.
24. Szabó Z, Váradi A, Li Q, Uitto J (2011) ABCC6 does not transport adenosine: Relevance to pathomechanism of pseudoxanthoma elasticum. Mol Genet Metab 104(3):421, author reply 422.
25. Tautenhahn R, Patti GJ, Rinehart D, Siuzdak G (2012) XCMS Online: A Web-based platform to process untargeted metabolomic data. Anal Chem 84(11):5035-5039.
26. Haug K, et al. (2013) MetaboLights-an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res 41(Database issue): D781-D786.
27. Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: Unity in diversity. Trends Biochem Sci 30(10):542-550.
28. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC (2004) Phosphateinduced vascular calcifi cation: Role of pyrophosphate and osteopontin. J Am Soc Nephrol 15(6):1392-1401.
29. Silcox DC, Jacobelli S, McCarty DJ (1973) Identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin. J Clin Invest 52(7):1595-1600.
30. Lazarowski ER (2012) Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8(3):359-373.
31. Roman RM, et al. (1997) Hepatocellular ATP-binding cassette protein expression enhances ATP release and autocrine regulation of cell volume. J Biol Chem 272(35):21970-21976.
32. Reisin IL, et al. (1994) The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269(32):20584-20591.
33. Rutsch F, et al. (2003) Mutations in ENPP1 are associated with "idiopathic" infantile arterial calcification. Nat Genet 34(4):379-381.
34. Le Boulanger G, et al. (2010) An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A 152A(1):118-123.
35. Nitschke Y, et al. (2012) Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 90(1):25-39.
36. St Hilaire C, et al. (2011) NT5E mutations and arterial calcifications. N Engl J Med 364(5):432-442.
37. Rutsch F, Nitschke Y, Terkeltaub R (2011) Genetics in arterial calcification: Pieces of a puzzle and cogs in a wheel. Circ Res 109(5):578-592.
38. Nitschke Y, Rutsch F (2012) Genetics in arterial calcification: Lessons learned from rare diseases. Trends Cardiovasc Med 22(6):145-149.
39. Harmey D, et al. (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164(4):1199-1209.
40. Kupetsky-Rincon EA, Li Q, Uitto J (2012) Magnesium reduces carotid intima-media thickness in a mouse model of pseudoxanthoma elasticum: A novel treatment biomarker. Clin Transl Sci 5(3):259-264.
41. Granda JL, Falvo KA, Bullough PG (1977) Pyrophosphate levels and magnesium oxide therapy in osteogenesis imperfecta. Clin Orthop Relat Res (126):228-231.
42. Hendig D, et al. (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52(2):227-234.
43. Price PA, Williamson MK, Nguyen TM, Than TN (2004) Serum levels of the fetuinmineral complex correlate with artery calcification in the rat. J Biol Chem 279(3):1594-1600.
44. Boraldi F, et al. (2013) Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls. J Invest Dermatol 133(4):946-954.
45. -/-). Biochem Biophys Res Commun 364(2):208-213.
46. O' Young J, et al. (2011) Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc 133(45):18406-18412.
47. O' Neill WC, Lomashvili KA, Malluche HH, Faugere MC, Riser BL (2011) Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79(5):512-517.
48. Riser BL, et al. (2011) Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 26(10):3349-3357.
49. Glatz AC, Pawel BR, Hsu DT, Weinberg P, Chrisant MR (2006) Idiopathic infantile arterial calcification: Two case reports, a review of the literature and a role for cardiac transplantation. Pediatr Transplant 10(2):225-233.
50. Rutsch F, et al.; GACI Study Group (2008) Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet 1(2):133-140.
51. Li Q, Schumacher W, Jablonski D, Siegel D, Uitto J (2012) Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene. Br J Dermatol 166(5):1107-1111.
52. Gorgels TG, et al. (2011) Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum. J Mol Med (Berl) 89(11):1125-1135.
53. Huitema LF, et al. (2006) The nitric oxide donor sodium nitroprusside inhibits mineralization in ATDC5 cells. Calcif Tissue Int 78(3):171-177.
54. Reid G, et al. (2003) Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol 63(5):1094-1103.
55. van de Wetering K, et al. (2007) Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol 72(2):387-394.